Business NewsPR NewsWire • Immunovia Announces Positive Results from the IMMray™ PanCan-d Verification Study

Immunovia Announces Positive Results from the IMMray™ PanCan-d Verification Study

Immunovia Announces Positive Results from the IMMray™ PanCan-d Verification Study

LUND, Sweden, Sept. 29, 2020 /PRNewswire/ -- Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced positive results from the verification study and will now commence the validation study, the...

View More : https://www.prnewswire.com:443/news-releases/immunovia-announces-positive-results-from-the-immray-pancan-d-verification-...
Releted News by prnewswire
Radius Health & Menarini Group Provide Elacestrant Update
Dutch Amarna Therapeutics enters research collaboration with Spanish FPS, examining the efficacy of its SV40-based SVec™ gene delivery vector platform technology in diabetes mellitus type 1 and multiple sclerosis
Immunovia Announces Positive Results from the IMMray™ PanCan-d Verification Study
Enesi Pharma's ImplaVax®-Enabled, Solid-Dose Modified Live Virus Vaccine Produces Neutralising Antibody and T-Cell Responses Equivalent to Liquid Vaccine Delivered via Needle and Syringe
Transform Materials Converts Abundant Natural Gas into High-Value Hydrogen and Acetylene
Color Star Technology Announces Change in Ticker Symbol